跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMYLIF 50 MG PELICULA BUCODISPERSABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EMYLIF 50 MG PELICULA BUCODISPERSABLE
Approved
STANDARD
EMYLIF 50 MG PELICULA BUCODISPERSABLE
Zambon S.P.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 4, 2023
Approval ID
8be4e76f6d2c5270
Company
Zambon S.P.A.
Type
Standard
Approval Details
Approval Id
8be4e76f6d2c5270
Drug Cima Aemps Name
EMYLIF 50 MG PELICULA BUCODISPERSABLE
Register Number
88570
Holder Company Name
Zambon S.P.A.
Marketing Company Name
Zambon S.A.U.
Authorization Date
2023-04-04
Dosage Form
PELICULA BUCODISPERSABLE
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Zambon S.P.A.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 4, 2023
Approval ID
8be4e76f6d2c5270
Type
Standard
Back to CIMA-AEMPS Approvals